COLL Stock Summary and Trading Ideas (Collegium Pharmaceutical | NASDAQ:COLL)

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

What symbol and exchange does Collegium Pharmaceutical shares trade?

Collegium Pharmaceutical trades on the NASDAQ stock market under the symbol COLL.

What is Collegium Pharmaceutical stock price doing today?

As of June 5, 2026, COLL stock price climbed to $33.38 with 319,484 million shares trading.

What is Collegium Pharmaceutical's Beta?

COLL has a beta of 1.38, meaning it tends to be more sensitive to market movements. COLL has a correlation of 0.15 to the broad based SPY ETF.

How much is Collegium Pharmaceutical worth?

COLL has a market cap of $1.08 billion. This is considered a Small Cap stock.

How much money does Collegium Pharmaceutical make?

Last quarter Collegium Pharmaceutical reported $194 million in Revenue and $1.76 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.30.

What is the highest and lowest price Collegium Pharmaceutical traded in the last 3 year period?

In the last 3 years, COLL traded as high as $50.79 and as low as $20.83.

What are the top ETFs holding Collegium Pharmaceutical?

The top ETF exchange traded funds that COLL belongs to (by Net Assets): IJR, VTI, IWM, VXF, AVUV.

Is Collegium Pharmaceutical (COLL) a good investment?

COLL has underperformed the market in the last year with a price return of +13.5% while the SPY ETF gained +25.0%. COLL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.7% and -3.0%, respectively, while the SPY returned +7.9% and -0.7%, respectively.

What are the support and resistance levels for Collegium Pharmaceutical (COLL)?

COLL support price is $31.76 and resistance is $33.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COLL shares will trade within this expected range on the day.